These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10160114)

  • 1. Costs, innovation and efficiency in anti-infective therapy.
    Bootman JL; Milne RJ
    Pharmacoeconomics; 1996; 9 Suppl 1():31-9. PubMed ID: 10160114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using pharmacoeconomics to assess the comparative value of antibacterials. A UK perspective.
    Davey P
    Pharmacoeconomics; 1996; 9 Suppl 1():26-30. PubMed ID: 10160113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current principles and application of pharmacoeconomics.
    Malek M
    Pharmacoeconomics; 1996; 9 Suppl 1():1-8. PubMed ID: 10160111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacoeconomics in helicobacter pylori infection (lecture)].
    Isakov VA; Ivanikov IO
    Ter Arkh; 2000; 72(2):61-3. PubMed ID: 10717932
    [No Abstract]   [Full Text] [Related]  

  • 6. Hospital management of complicated intra-abdominal infections: pharmacoeconomic evaluation.
    Eandi M
    J Chemother; 2009 Jul; 21 Suppl 1():44-55. PubMed ID: 19622451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoeconomic Evaluations: Guidelines for Drug Purchasers.
    Langley PC; Sullivan SD
    J Manag Care Spec Pharm; 2020 Jun; 26(6):689-695. PubMed ID: 32463775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug therapies for sexually transmitted diseases. Clinical and economic considerations.
    Bowie WR
    Drugs; 1995 Apr; 49(4):496-515. PubMed ID: 7789285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of pharmacoeconomics and pharmaceutical outcomes evaluations.
    Reeder CE
    Am J Health Syst Pharm; 1995 Oct; 52(19 Suppl 4):S5-8. PubMed ID: 8846244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-effectiveness of new drugs impacts reimbursement decision making but room for improvement].
    Hoomans T; van der Roer N; Severens JL; Delwel GO
    Ned Tijdschr Geneeskd; 2010; 154():A958. PubMed ID: 20699045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacoeconomic evaluation of use of ciprofloxacin and norfloxacin with cost-benefit analysis].
    Skrbo A; Selava A; Zunić L
    Med Arh; 2003; 57(5-6):285-9. PubMed ID: 15022580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacoeconomics in contemporary medicine].
    Czech M
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():16-9. PubMed ID: 15524007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoeconomics comes of age?
    Walley T; Breckenridge A
    Clin Pharmacol Ther; 2008 Aug; 84(2):279-80. PubMed ID: 18563057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A guideline for the use of pharmacoeconomic models of diabetes treatment in the US managed-care environment.
    Veenstra DL; Ramsey SD; Sullivan SD
    Pharmacoeconomics; 2002; 20 Suppl 1():21-30. PubMed ID: 12036381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoeconomics and formulary decision making.
    Sanchez LA
    Pharmacoeconomics; 1996; 9 Suppl 1():16-25. PubMed ID: 10160112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How should we evaluate new anti-infectives for respiratory tract infections?
    Paladino JA
    Can Respir J; 1999; 6 Suppl A():31A-4A. PubMed ID: 10202231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoeconomics of appropriate antimicrobial use.
    Davey P
    Diagn Microbiol Infect Dis; 1995; 22(1-2):225-9. PubMed ID: 7587044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoeconomics.
    Ahuja J; Gupta M; Gupta AK; Kohli K
    Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of pharmacoeconomics in the research and development decision-making process.
    DiMasi JA; Caglarcan E; Wood-Armany M
    Pharmacoeconomics; 2001; 19(7):753-66. PubMed ID: 11548911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitfalls associated with commonly used methods for pharmacoeconomic analyses.
    Klepser DG
    Pharmacotherapy; 2002 Feb; 22(2 Pt 2):35S-38S. PubMed ID: 11837545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.